Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-17-027486

Director sold 1,707 shares at an average $20.21 ($34,498)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2017-11-24 Sale −1,507 $20.21 $30,450 53,940 D
Bolzon Bradley J PhD Director 2017-11-27 Sale −200 $20.24 $4,048 53,740 D
Open-market sales · 1,707 sh · avg $20.21 · $34,498
Loading xslF345X03/doc4.xml…